BRIEF published on 11/20/2025 at 15:50, 7 months 9 days ago The Vanguard Group Discloses Position in Mural Oncology plc Form 8.3 Vanguard Group Shareholding Irish Takeover Mural Oncology
BRIEF published on 11/20/2025 at 15:50, 7 months 9 days ago Le groupe Vanguard révèle sa participation dans Mural Oncology plc Actionnariat Groupe Vanguard Formulaire 8.3 Prise De Contrôle Irlandaise Oncologie Murale
PRESS RELEASE published on 11/20/2025 at 15:50, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.47% stake in American Axle & Manufacturing Holdings, Inc. as per Form 8.3 under the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure American Axle
BRIEF published on 11/20/2025 at 15:49, 7 months 9 days ago The Vanguard Group Discloses Position in Greencore Group Securities Disclosure Takeover Code Vanguard Group Greencore Group
BRIEF published on 11/20/2025 at 15:49, 7 months 9 days ago Le groupe Vanguard révèle sa participation dans le groupe Greencore. Titres Groupe Vanguard Code De Prise De Contrôle Divulgation Groupe Greencore
PRESS RELEASE published on 11/20/2025 at 15:48, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.05% position in JTC plc's 1p ordinary securities as of 19 November 2025 Position Disclosure The Vanguard Group 1p Ordinary Securities 5.05% JTC Plc
BRIEF published on 11/20/2025 at 15:48, 7 months 9 days ago Vanguard Group Discloses Position in Bluefield Solar Income Fund Form 8.3 Takeover Code Securities Disclosure Vanguard Group Bluefield Solar
BRIEF published on 11/20/2025 at 15:48, 7 months 9 days ago Le groupe Vanguard révèle sa participation dans le fonds Bluefield Solar Income. Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Information Sur Les Valeurs Mobilières Bluefield Solar
PRESS RELEASE published on 11/20/2025 at 15:46, 7 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group discloses a 5.71% stake in Avadel Pharmaceuticals plc. Form 8.3 submitted to the Irish Takeover Panel on 20-Nov-2025 Form 8.3 Irish Takeover Panel Vanguard Group Stake Disclosure Avadel Pharmaceuticals Plc
BRIEF published on 11/20/2025 at 15:46, 7 months 9 days ago The Vanguard Group Discloses Interests in Spire Healthcare Form 8.3 Takeover Code Spire Healthcare Shareholding Vanguard
Published on 06/30/2026 at 00:05, 1 hour 32 minutes ago American Critical Minerals Announces Completion of Warrant Exercise Incentive Program
Published on 06/29/2026 at 23:46, 1 hour 51 minutes ago 1933 Industries Reports Third Quarter 2026 Financial Results
Published on 06/29/2026 at 22:01, 3 hours 36 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/29/2026 at 15:00, 10 hours 37 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 10 hours 37 minutes ago Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 22:47, 2 hours 50 minutes ago Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 3 hours 32 minutes ago ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 3 hours 32 minutes ago Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 5 hours 7 minutes ago Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
Published on 06/29/2026 at 20:00, 5 hours 37 minutes ago IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
Published on 06/29/2026 at 18:30, 7 hours 7 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 7 hours 7 minutes ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 7 hours 52 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros
Published on 06/29/2026 at 17:45, 7 hours 52 minutes ago Déclaration hebdomadaire de rachat d'actions
